According to Benzinga Pro, Hims & Hers Health's peer group average for short interest as a percentage of float is 10.67%, ...

Citigroup raised the price target for the Hims & Hers Health Inc (NYSE:HIMS) stock from “a Buy” to “a Neutral”. The rating was released on May 22, 2024, according to finviz. We previously noted in ...

Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.

Kroger Health's Little Clinics plan to offer Wegovy, Zepbound and other medications as part of its relaunched weight ...

Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS – Research ...

Caron Treatment Centers has started an Aviation Assessment Program for aviation professionals referred by the Federal ...

Here is how Acrivon Therapeutics, Inc. (ACRV) and Hims & Hers Health, Inc. (HIMS) have performed compared to their sector so far this year.

Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy. Hims & Hers Health stock declined ...

More than a year after Jesse Malin suffered a rare spinal cord stroke, a tribute album of artists singing his songs is being ...

After dropping initially, equity markets are shrugging off a much hotter-than-expected jobs report. While not a full-fledged rally, the market seems to be ignoring the headline number and paying more ...